Latest Shareholder Approval News

Euroz Hartleys Group Limited has secured shareholder approval for a $63 million capital return, marking a significant milestone in its long history of shareholder distributions.

Resolution Minerals has addressed ASX concerns over recent share price and volume spikes, attributing the activity to ongoing developments in its US Horse Heaven project acquisition.

Ironbark Capital Limited has announced an on-market buy-back of up to 10.46 million ordinary shares, commencing July 21, 2025, and running through to July 2026. This move signals a strategic capital management initiative without requiring shareholder approval.

Strickland Metals plans a capital return by distributing 1.2 billion Gateway Convertible Preference Shares to its shareholders, significantly reducing its stake and reshaping ownership. The move awaits shareholder approval and hinges on conditions tied to an asset sale agreement.

Connected Minerals reports promising uranium grades from its maiden drilling at Namibia’s Etango North-East project, aligning closely with nearby world-class deposits, while advancing rare earth exploration in Western Australia.

Sipa Resources has successfully raised A$1.61 million through a strongly supported placement, positioning the company to advance multiple gold exploration projects across South Australia and Western Australia.

Highfield Resources has extended the exclusivity period with Qinghai Salt Lake Industry for a proposed US$300 million cornerstone equity placement, allowing more time for due diligence and negotiations. The company is also advancing its Canadian Southey potash project acquisition.

Openn Negotiation Ltd moves forward with a creditor-approved recapitalisation plan following voluntary administration, while its shares remain suspended on the ASX.

Scalare Partners has raised $3 million through a share placement to fund its acquisition of Tank Stream Labs, alongside a $1.08 million Share Purchase Plan for existing shareholders. This capital raise aims to bolster Scalare’s position in the flexible workspace and tech investment sectors.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

Nova Minerals has closed a US$11.1 million underwritten offering on NASDAQ, positioning itself to advance exploration and feasibility studies at its Estelle Gold and Critical Minerals Project in Alaska.

Pacific Edge Limited has opened a $5 million Share Purchase Plan at $0.10 per share, conditional on shareholder approval of a prior $16.1 million Placement. The capital raise aims to extend the company’s cash runway and accelerate US market adoption of its bladder cancer diagnostic tests amid Medicare non-coverage.